PATENT CLAIM ANALYSIS

Application Number: 15862232
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["435", "091200"]

Abstract:
Disclosed are DNA polymerases having increased reverse transcriptase efficiency relative to a corresponding, unmodified polymerase. The polymerases are useful in a variety of disclosed primer extension methods. Also disclosed are related compositions, including recombinant nucleic acids, vectors, and host cells, which are useful, e.g., for production of the DNA polymerases.

Claim (Index 19):
A method for conducting a Mg2+-based reverse transcription polymerase chain reaction (RT-PCR), comprising contacting a DNA polymerase with a primer, a polynucleotide template, Mg2+, and nucleoside triphosphates under conditions suitable for RT-PCR, wherein the DNA polymerase comprises an amino acid sequence at least 95% identical to the amino acid sequence of SEQ ID NO:1 and the amino acid of the DNA polymerase corresponding to position 616 of SEQ ID NO:1 is any amino acid other than I.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 86.0
- Lexical Diversity: 1.42857
- Patent Class: 435.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13706103', '15223992', '14578228', '13706107', '15709855']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6856367486686104
- 35 USC 102 Novelty (BERT): 0.5722866688018209
- Combined Prediction Score: 0.6743017406819315
- Mean Citation Score: 453.47393200000016
- Max Citation Score: 462.05444000000006
- Similarity Product: 457.29008304152967

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test